_id

690da979ccc777a4e85d084f

Ticker

ADAG

Name

Adagene Inc

Exchange

NASDAQ

Address

Building C14, Suzhou, China, 215123

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.adagene.com

Description

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. The company was incorporated in 2011 and is headquartered in Suzhou, China.

Last Close

1.75

Volume

173766

Current Price

1.67

Change

-4.571428571428576

Last Updated

2025-11-28T11:50:32.491Z

Image

data:image/webp;base64,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

Ipo Date

2021-02-09T00:00:00.000Z

Market Cap

84836288

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9946666666666667

Sentiment Sources

3

Rating

3.3333

Target Price

9.514

Strong Buy

0

Buy

1

Hold

2

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

-

Cost Of Revenue

300326

Gross Profit

-300326

Operating Expenses

15426494

Operating Income

-15726821

Interest Expense

319204

Pretax Income

-13509909

Net Income

-13510369

Eps

-0.35845277541527915

Dividends Per Share

-

Shares Outstanding

47131270

Income Tax Expense

459.13

EBITDA

-12890382

Operating Margin

-

Total Other Income Expense Net

2216911

Cash

62829235

Short Term Investments

-

Receivables

2449

Inventories

-

Total Current Assets

65364486

Property Plant Equipment

1115958

Total Assets

66517885

Payables

3626285

Short Term Debt

6761343

Long Term Debt

-

Total Liabilities

28605445

Equity

37912440

Depreciation

300326

Change In Working Capital

1512875

Cash From Operations

-11156630

Capital Expenditures

2499

Cash From Investing

242204

Cash From Financing

-11633111

Net Change In Cash

-22365267

PE

-

PB

1.7397689518268935

ROE

-35.635714820781786

ROA

-20.31088180269111

FCF

-11159129

Fcf Percent

-

Piotroski FScore

1

Health Score

39

Deep Value Investing Score

3.5

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

2.8

Garp Investing Score

1.5

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

3.5

Quality Investing Score

2

Value Investing Score

3.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

-

Quarters > 0 > income Statement > cost Of Revenue

300326

Quarters > 0 > income Statement > gross Profit

-300326

Quarters > 0 > income Statement > operating Expenses

15426494

Quarters > 0 > income Statement > operating Income

-15726821

Quarters > 0 > income Statement > interest Expense

319204

Quarters > 0 > income Statement > pretax Income

-13509909

Quarters > 0 > income Statement > net Income

-13510369

Quarters > 0 > income Statement > eps

-0.35845277541527915

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

37690792

Quarters > 0 > income Statement > income Tax Expense

459.13

Quarters > 0 > income Statement > EBITDA

-12890382

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

2216911

Quarters > 0 > balance Sheet > cash

62829235

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

2449

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

65364486

Quarters > 0 > balance Sheet > property Plant Equipment

1115958

Quarters > 0 > balance Sheet > total Assets

66517885

Quarters > 0 > balance Sheet > payables

3626285

Quarters > 0 > balance Sheet > short Term Debt

6761343

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

28605445

Quarters > 0 > balance Sheet > equity

37912440

Quarters > 0 > cash Flow > net Income

-13510369

Quarters > 0 > cash Flow > depreciation

300326

Quarters > 0 > cash Flow > change In Working Capital

1512875

Quarters > 0 > cash Flow > cash From Operations

-11156630

Quarters > 0 > cash Flow > capital Expenditures

2499

Quarters > 0 > cash Flow > cash From Investing

242204

Quarters > 0 > cash Flow > cash From Financing

-11633111

Quarters > 0 > cash Flow > net Change In Cash

-22365267

Quarters > 0 > ratios > PE

-0.35845277541527915

Quarters > 0 > ratios > PB

1.7397689518268935

Quarters > 0 > ratios > ROE

-35.635714820781786

Quarters > 0 > ratios > ROA

-20.31088180269111

Quarters > 0 > ratios > FCF

-11159129

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

39

Quarters > 1 > quarter

2024-12-31

Quarters > 1 > income Statement > revenue

103204

Quarters > 1 > income Statement > cost Of Revenue

926248

Quarters > 1 > income Statement > gross Profit

-823044

Quarters > 1 > income Statement > operating Expenses

26893831

Quarters > 1 > income Statement > operating Income

-26790627

Quarters > 1 > income Statement > interest Expense

423546

Quarters > 1 > income Statement > pretax Income

-24936500

Quarters > 1 > income Statement > net Income

-24918253

Quarters > 1 > income Statement > eps

-0.6787465418135821

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

36712162

Quarters > 1 > income Statement > income Tax Expense

-18247

Quarters > 1 > income Statement > EBITDA

-22702523

Quarters > 1 > income Statement > operating Margin

-25958.90372466184

Quarters > 1 > income Statement > total Other Income Expense Net

1854127

Quarters > 1 > balance Sheet > cash

85194502

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

8309

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

87778005

Quarters > 1 > balance Sheet > property Plant Equipment

1409034

Quarters > 1 > balance Sheet > total Assets

89268425

Quarters > 1 > balance Sheet > payables

4241773

Quarters > 1 > balance Sheet > short Term Debt

17933896

Quarters > 1 > balance Sheet > long Term Debt

417339

Quarters > 1 > balance Sheet > total Liabilities

38744581

Quarters > 1 > balance Sheet > equity

50523844

Quarters > 1 > cash Flow > net Income

-24918253

Quarters > 1 > cash Flow > depreciation

668279

Quarters > 1 > cash Flow > change In Working Capital

-2169749

Quarters > 1 > cash Flow > cash From Operations

-23014126

Quarters > 1 > cash Flow > capital Expenditures

27306

Quarters > 1 > cash Flow > cash From Investing

662885

Quarters > 1 > cash Flow > cash From Financing

5205286

Quarters > 1 > cash Flow > net Change In Cash

-10479285

Quarters > 1 > ratios > PE

-0.6787465418135821

Quarters > 1 > ratios > PB

1.2716032354941165

Quarters > 1 > ratios > ROE

-49.31978849431963

Quarters > 1 > ratios > ROA

-27.91384859764245

Quarters > 1 > ratios > FCF

-23041432

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-223.2610363939382

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2024-09-30

Quarters > 2 > income Statement > revenue

-

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

9160916

Quarters > 2 > income Statement > operating Income

-9160916

Quarters > 2 > income Statement > interest Expense

428328

Quarters > 2 > income Statement > pretax Income

-8505164

Quarters > 2 > income Statement > net Income

-8505858

Quarters > 2 > income Statement > eps

-0.24071126527152548

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

35336352

Quarters > 2 > income Statement > income Tax Expense

694

Quarters > 2 > income Statement > EBITDA

-8961017

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

655752

Quarters > 2 > balance Sheet > cash

95673787

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

31419

Quarters > 2 > balance Sheet > inventories

1

Quarters > 2 > balance Sheet > total Current Assets

98804568

Quarters > 2 > balance Sheet > property Plant Equipment

1693150

Quarters > 2 > balance Sheet > total Assets

100779599

Quarters > 2 > balance Sheet > payables

3370641

Quarters > 2 > balance Sheet > short Term Debt

16116193

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

44192011

Quarters > 2 > balance Sheet > equity

56587588

Quarters > 2 > cash Flow > net Income

-8505858

Quarters > 2 > cash Flow > depreciation

257969

Quarters > 2 > cash Flow > change In Working Capital

279294

Quarters > 2 > cash Flow > cash From Operations

-6686859

Quarters > 2 > cash Flow > capital Expenditures

6274

Quarters > 2 > cash Flow > cash From Investing

223621

Quarters > 2 > cash Flow > cash From Financing

-1436066

Quarters > 2 > cash Flow > net Change In Cash

-7130235

Quarters > 2 > ratios > PE

-0.24071126527152548

Quarters > 2 > ratios > PB

1.0927946955434822

Quarters > 2 > ratios > ROE

-15.031313934073317

Quarters > 2 > ratios > ROA

-8.440059381462712

Quarters > 2 > ratios > FCF

-6693133

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-06-30

Quarters > 3 > income Statement > revenue

-

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

9160916

Quarters > 3 > income Statement > operating Income

-9160916

Quarters > 3 > income Statement > interest Expense

428328

Quarters > 3 > income Statement > pretax Income

-8505164

Quarters > 3 > income Statement > net Income

-8505858

Quarters > 3 > income Statement > eps

-0.19256900785753983

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

44170441

Quarters > 3 > income Statement > income Tax Expense

694

Quarters > 3 > income Statement > EBITDA

-8961017

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

655752

Quarters > 3 > balance Sheet > cash

95673787

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

31418

Quarters > 3 > balance Sheet > inventories

1

Quarters > 3 > balance Sheet > total Current Assets

98804568

Quarters > 3 > balance Sheet > property Plant Equipment

1693150

Quarters > 3 > balance Sheet > total Assets

100779599

Quarters > 3 > balance Sheet > payables

3370641

Quarters > 3 > balance Sheet > short Term Debt

15974912

Quarters > 3 > balance Sheet > long Term Debt

4560251

Quarters > 3 > balance Sheet > total Liabilities

44192011

Quarters > 3 > balance Sheet > equity

56587588

Quarters > 3 > cash Flow > net Income

-8505858

Quarters > 3 > cash Flow > depreciation

257969

Quarters > 3 > cash Flow > change In Working Capital

279294

Quarters > 3 > cash Flow > cash From Operations

-6686859

Quarters > 3 > cash Flow > capital Expenditures

6274

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-718033

Quarters > 3 > cash Flow > net Change In Cash

-7130235

Quarters > 3 > ratios > PE

-0.19256900785753983

Quarters > 3 > ratios > PB

1.3659934003548624

Quarters > 3 > ratios > ROE

-15.031313934073317

Quarters > 3 > ratios > ROA

-8.440059381462712

Quarters > 3 > ratios > FCF

-6693133

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

39

Valuation > metrics > PE

-0.35845277541527915

Valuation > metrics > PB

1.7397689518268935

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-35.635714820781786

Profitability > metrics > ROA

-20.669280563148618

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.7545134261999491

Risk > metrics > Interest Coverage

-49.268871943960605

Risk > final Score

-149

Risk > verdict

High

Liquidity > metrics > Current Ratio

6.29253242414919

Liquidity > metrics > Quick Ratio

6.29253242414919

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-205

Prev Risks > 1

-38

Prev Risks > 2

-38

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T11:17:40.431Z